GC
HITK

Guggenheim Capital’s HI-TECH PHARMACAL INC HITK Stock Holding History

Guggenheim Capital’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-64,001
Closed -$2.77M – 3419
2014
Q1 		$2.77M Buy
64,001
+32,805
+105% +$1.42M 0.01% 1513
2013
Q4 		$1.35M Sell
31,196
-1,829
-6% -$79K ﹤0.01% 2069
2013
Q3 		$1.43M Buy
+33,025
New +$1.26M 0.01% 1866

Guggenheim Capital's HITK Position: Q2 2014 in Review

Guggenheim Capital sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 64,001 shares — an estimated $2.77M sold.

Guggenheim Capital first reported a position in HITK in Q3 2013 and held it in 3 quarters. The position peaked at $2.77M in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Guggenheim Capital reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Guggenheim Capital sold 64,001 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $2.77M.
  • Guggenheim Capital first reported a position in HI-TECH PHARMACAL INC in Q3 2013 and held it in 3 quarters.
  • Guggenheim Capital's HI-TECH PHARMACAL INC position peaked at $2.77M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.